BioNexus Becomes First Nasdaq-Listed Firm to Approve Ethereum Treasury
The tech firm will prioritize Ethereum over Bitcoin as a strategic asset, touting the asset's potential as a "financial instrument."
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This ethereum story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
Ethereum Dancing on Two Fronts as Quantum Upgrade Advances and Treasury Leverage Bites
Ethereum developers want to upgrade the network to be quantum-ready by 2027, potentially accelerating one of its biggest security...
MSCI Cuts Strategy From Global Indexes, Putting Bitcoin Treasury Model Under Pressure
Key Takeaways: Under new classification rules instituted by MSCI, Strategy will be phased out of the global equity index. The chan...
AVAX One drops data center plans to go all in on Avalanche treasury strategy
AVAX One's pivot to focus on Avalanche staking highlights a strategic shift towards digital asset reliance, increasing exposure to...
Bitcoin ETFs Shed $2.35 Billion in Two Weeks as BlackRock’s Outflow Streak Hits 11
Bitcoin ETF outflows have reached $2.347 billion across the first two completed November trading weeks, leaving a persistent hole...
Bitcoin Price Today: Negative Funding Rates Signal Growing Bearish Bets as BTC Nears $68K
The latest data presents a mixed picture, however, as Hyperliquid whales have returned to net-long positions despite deteriorating...
USDC Treasury mints 250M USDC on Solana, boosting network liquidity
The increased USDC supply on Solana may alter liquidity dynamics, potentially affecting asset prices and market sentiment on the n...